Results 1 to 10 of about 3,733 (171)

Part 1 - imidazolines and the changing face of nasal decongestants [PDF]

Frontiers in Pharmacology
Imidazolines are sympathomimetic drugs used to treat a range of conditions including nasal congestion, ocular disorders, and hypertension. Imidazolines were discovered over 150 years ago.
Rebecca J. Stinson, Laura R. Sadofsky
exaly   +4 more sources

Nasal decongestants in monotherapy for the common cold [PDF]

The Cochrane Library, 2016
Many treatments for the common cold exist and are sold over-the-counter. Nevertheless, evidence on the effectiveness and safety of nasal decongestants is limited.To assess the efficacy, and short- and long-term safety, of nasal decongestants used in monotherapy to alleviate symptoms of the common cold in adults and children.We searched the Cochrane ...
An De Sutter, Laura Deckx, Mieke van Driel   +2 more
exaly   +6 more sources

Assessment of the Prevalence of the Use of Nasal Decongestants Among Hail Population

Journal of Pharmacy and Bioallied Sciences
Background: Nasal decongestants are widely used to relieve nasal congestion caused by conditions such as allergic rhinitis, sinusitis, and the common cold.
Farida Habib Khan, Abdullah D Alotaibi, Amal Daher Alshammari, Mohammed Alateeq, Muath Alshmmari, Read Alharbi, Rakhi Issrani   +6 more
doaj   +2 more sources

Nasal decongestants in the treatment of nasal obstruction

Медицинский совет, 2021
Nasal congestion is one of the most common symptoms of common colds and rhinitis, due to an inflammatory reaction, vasodilation, increased nasal blood flow and vascular permeability.
K. A. Nikitin, S. V. Baranskaya
doaj   +3 more sources

Part II – imidazolines and rhinitis medicamentosa: how can we tackle the rebound dilemma? [PDF]

Frontiers in Pharmacology
Rhinitis medicamentosa is the state of chronic congestion experienced from the prolonged or excessive use of nasal vasoconstrictors, typically used in the treatment of nasal congestion.
Rebecca J. Stinson, Laura R. Sadofsky
doaj   +2 more sources

WITHDRAWN: Nasal decongestants for the common cold. [PDF]

Cochrane Database Syst Rev, 2009
The common cold is a major and recurrent cause of morbidity, on average affecting children and adults two or more times each year. Nasal congestion is its commonest symptom and many therapies are marketed for its relief. There is no meta-analysis of controlled clinical trials on the effects of nasal decongestants in the common cold.To assess the ...
Taverner D, Latte GJ.
europepmc   +4 more sources

Rhinitis medicamentosa

Journal of Education, Health and Sport
Introduction: Rhinitis medicamentosa (RM) is a chronic inflammatory condition of the nasal mucosa caused by excessive use of topical nasal decongestants.
Martyna Byrska, Hanna Barska-Kobylińska, Marta Janura, Maja Weimann , Grzegorz Przywara, Oliwia Biegańska, Emilia Biczak, Ewa Katarzyna Malaka , Marlena Zubiak, Sara Langner   +9 more
doaj   +2 more sources

ADVERSE EFFECTS OF NASAL DECONGESTANTS (REVIEW OF LITERATURE)

Неонатологія, хірургія та перинатальна медицина, 2022
Nasal decongestants are ones of the most popular and widespread medicines due to high frequency of respiratory infections. But on the other hand they are characterized by significant abuse potential for users seeking such effects as euphoria ...
C. Левицька
doaj   +1 more source

Pathogenetic features of acute naphazoline poisoning in children [PDF]

Research Results in Pharmacology, 2021
Introduction: Acute poisoning by nasal decongestants is an important issue in pediatrics due to physiological and anatomical characteristics of the child’s body and pharmacokinetics of drugs in early childhood.
Ekaterina S. Karpushkina, Olga A. Zhdanova, Galina A. Batishcheva, Yulia A. Petukhova   +3 more
doaj   +3 more sources

Awareness of the Unaizah populations in Al-Qassim province in Saudi Arabia regarding nasal decongestant use for allergic rhinitis and their side effect

Journal of Family Medicine and Primary Care, 2022
Background: Nasal decongestant drugs are widely used as potent vasoconstrictive agents to reduce congestion of nasal and ocular mucous membranes in disease such as allergic rhinitis.
Abdulhakeem Almutairi, Homood Almutairi, Faisal A Althwiny, Abdulrahman Almutairi, Saleh Alwasil, Naif Albadrani, Yazeed Aljeri, Muath Alawad   +7 more
doaj   +1 more source